Clinical performance and treatment of non-ST infarction

Non-ST lift myocardial infarction (NSTEMI) is a common and serious type of acute coronary artery syndrome:Clinical performance — chest pain: The most prominent and common symptoms are that the pain is located in the back of the chest or in the front of the heart, which can be radiationed from the left shoulder, the inner arm of the left arm, the neck, the lower jaw, etc. The pain is often of a squeezing, irritating or condensing nature, to varying degrees, but it usually lasts longer than 20 minutes and does not significantly alleviate the pain after resting or containing nitric acid glycerine and is clearly different from stable heart pain.• Other associated symptoms: respiratory difficulties can be associated with the loss of the heart function as a result of myocardial infarction, and the loss of lung blood, which affects the exchange of gases; some patients also suffer from conditions such as nausea, vomiting, sweating, heart palsy, inactivity, most of which are due to the reduction of the blood function of the heart pump, the insufficiency of organs such as the gastrointestinal tract and the disruption of the autonomous nervous function. However, there are specific groups of people, such as the elderly, diabetics and others, who may have unusual symptoms, which can be manifested in mild chest suffocation, breathing difficulties or even symptoms, and can easily be ignored and delayed in diagnosis.Principles and measures of treatment: general treatment::: Rest: If a patient suspects or is diagnosed with an infarction of a non-ST section, he or she needs to rest in bed immediately, keep the environment quiet, reduce outside stimulation, avoid emotional stress, severe defecation, etc., which increases the burden of the heart, and keep the heart in a relatively relaxed state, which is conducive to abating symptoms and recovery.Oxygen: Oxygen treatment, improvement of myocardial myocardial hypoxia, usually using nose catheters or mask oxygen, adjustment of oxygen flow to the patient ‘ s haematological saturation, etc., and generally maintenance of blood oxygen saturation above 95%.:: Symptoms: For patients suffering from chest pain, appropriate pain relief can be provided with pain relief drugs, commonly used, such as morphine and thorium, which not only relieve the patient ‘ s pain, but also ease stress, reduce neurological excitement and reduce the heart burden.Anti-blood tablet treatment: this is a key part of the treatment, with aspirin, chlorprorey, Triglo, etc. commonly used drugs. Aspirin generally needs to be chewed as quickly as possible, followed by long-term maintenance, while drugs such as chlorpelle and Brillo concentrate through different mechanisms, usually combined with aspirin, especially for patients in need of intervention, enhanced antisphyllic treatment, can reduce the risk of leaching and improve the blood flow from the heart.:: Anticondensation treatment: use of anticondensed drugs such as hepatin, low-molecular heparin, inhibiting blood condensation, preventing further expansion and development of the haematosis, and maintaining a smooth flow of blood within the coronary artery, which works mainly by enhancing the activity of the anticondensation enzyme III, inhibiting the activity of the condensation factor, often in conjunction with the anti blood tablets, and increasing the effectiveness of treatment.:: Anti-myocardial ischaemic treatment:Nitrate-type drugs: e.g., nitrate glycerine, which can increase the blood supply by expanding the coronary artery, while expanding the outer circumcisary vessels, reducing the pre- and post-heart load and mitigating the symptoms of cardiac pain. Medicines are given in a variety of ways, and they can be administered under the tongue (for the relief of acute chest pains), or with an intravenous drip (for the continued myocardial insinuation) etc., depending on the severity of the condition and the patient ‘ s response.• Beta Receptor retardants: Medicines such as Metolore and Pislore can slow down the heart rate, reduce the oxygen consumption of myocardial muscles, improve myocardial hemorrhage and protect the heart function. However, when used, the patient ‘ s heart rate, blood pressure, heart function etc. must be carefully assessed and the patient ‘ s heart rate is too slow, low blood pressure, acute heart failure etc. must be used or disabled to avoid aggravating conditions.• Calcium route retardants: Calcium route retardants, such as nitrobenzene, thiram and thiram, may be used to mitigate myocardial hemorrhage when the patient is unable to withstand beta receptor retardants or when there is a mutation-type cardiac pain. Care should also be taken of its adverse effects and taboos, such as low blood pressure, a hypothermia, etc. Patients and their families need to respond to medical personnel in a timely manner if blood pressure decreases or their heart rate slows down.Re-infusion treatment:PCI: This is a clinically used and effective re-injection treatment that expands through catheters to narrow parts of the coronary artery and can be implanted into a support frame, restores the blood flow of the coronary artery and improves the blood supply of the heart muscle, generally requiring that it take as little as possible within 12 hours of the onset of the disease, the shorter the time the heart muscle is saved and the better the better. For some high-risk non-ST patients who carry high-cardiological infarction, even if early electrocardiograms are not typical, a coronary aneurysm may be carried out ahead of time to determine whether or not to proceed immediately with PCI treatment based on the results.CABG: For patients who are not fit for PCI, such as multiple vascular pathologies and complex pathologies, coronary artery trajectories can be considered, i.e. often referred to as cardiac bridging operations, which use their own veins to establish bypass roads at the close and far end of the coronary artery to ensure the blood supply of the heart muscles, but which is relatively traumatic and has a long post-operative recovery period, requiring careful choice after a combination of the patient ‘ s physical condition, the condition of the disease, etc.Other treatments: attention must also be paid to the complications of the patient, such as a heart disorder and the corresponding treatment for a heart disorder; heart failure requires active anticardial failure treatment, etc., while the basic indicators of blood pressure, blood sugar, etc. are regulated, the internal environment is stable and the overall health of the patient is guaranteed.Knowledge of non-ST-related infarction of sexual myocardial infarction is important for improving the health status of patients by increasing the vigilance of the disease, timely detection and treatment.